Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

The Dawn of a New Weapon: Recombinant Oncotoxin TP4O Enters the Battle Against Superficial Bladder Cancer

Phase I clinical trial results of recombinant oncotoxin TP4O for treating superficial bladder cancer, showing promising safety and efficacy data.

Jacob Howard
Aug 08, 2025

Popular Articles